Medicare Announces Temporary GLP-1 Weight Management Medication Program
Beginning July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) is launching a temporary demonstration program designed to provide eligible Medicare beneficiaries access to select GLP-1 weight management medications that are not currently covered under standard Medicare Part D prescription drug coverage.
The program is scheduled to run through December 31, 2027.
What Is the CMS GLP-1 Bridge Program?
The CMS GLP-1 Bridge Program is a Medicare-administered demonstration project that may help eligible beneficiaries obtain certain FDA-approved weight management medications through a separate Medicare process.
This program operates independently from Medicare Advantage and Medicare Part D plans.
Who May Be Eligible?
Eligibility is determined by Medicare and the beneficiary's healthcare provider. In general, individuals must:
- Be enrolled in Medicare with Part D prescription drug coverage.
- Meet Medicare's clinical eligibility requirements.
- Not already qualify for GLP-1 medication coverage under existing Medicare Part D rules.
What Medications Are Included?
At launch, the program is expected to include select GLP-1 weight management medications approved by CMS.
Medication availability and coverage are subject to change based on CMS guidance.
What Will Members Pay?
Eligible beneficiaries approved through the program are expected to pay a copayment of approximately $50 for a one-month supply of medication.
Please note: Costs associated with this program do not count toward Medicare Part D deductibles or out-of-pocket spending accumulations.
Cost-sharing is determined by Medicare and may be subject to future program updates.
How Do I Apply?
If you are interested in learning whether this program may be right for you:
- Speak with your healthcare provider.
- Discuss whether a GLP-1 weight management medication is medically appropriate for your situation.
- Your healthcare provider can help determine eligibility and explain the next steps in the Medicare approval process.
Important Information
The CMS GLP-1 Bridge Program is administered directly by Medicare. Medicare health plans, prescription drug plans, brokers, and agents do not determine:
- Eligibility
- Prior authorization approvals
- Covered medications
- Cost-sharing amounts
- Claims processing decisions
For the most current information, beneficiaries should consult their healthcare provider or Medicare directly.
Disclaimer
Information provided is for educational purposes only and is subject to change based on guidance from the Centers for Medicare & Medicaid Services (CMS).
Eligibility and coverage decisions are made by Medicare and participating healthcare providers.